Juli Miller | Director, IR |
James Noble | CEO |
Helen Tayton-Martin | Chief Business Officer |
Adrian Rawcliffe | CFO |
Rafael Amado | Chief Medical Officer |
Gwen Binder | Chief Technology Officer |
Jonathan Chang | Leerink Partners |
Tony Butler | Guggenheim Securities |
Robyn Karnauskas | Citi |
Peter Lawson | SunTrust |
Reni Benjamin | Raymond James |
Eric Schmidt | Cowen and Company |
Nick Abbott | Wells Fargo |
Jenny Leeds | Bank of America |
Good day, ladies and gentlemen. And welcome to the Adaptimmune Q1 2018 Earnings Call and Business Update. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the call over to Juli Miller.
You may begin.